RMFCX
Price
$62.31
Change
-$0.09 (-0.14%)
Updated
Jun 22 closing price
Net Assets
116.64B
SMDLX
Price
$25.16
Change
+$0.07 (+0.28%)
Updated
Jun 22 closing price
Net Assets
369.7M
Interact to see
Advertisement

RMFCX vs SMDLX

RMFCX vs SMDLX Comparison Chart in %
View a ticker or compare two or three
VS
RMFCX vs. SMDLX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Hold and SMDLX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 117B vs. SMDLX (370M). SMDLX pays higher dividends than RMFCX: SMDLX (2.33) vs RMFCX (1.19). RMFCX was incepted earlier than SMDLX: RMFCX (24 years) vs SMDLX (26 years). SMDLX (2.10) is less costly to investors than RMFCX (0.91). SMDLX is a more actively managed with annual turnover of: 79.00 vs. RMFCX (30.00). RMFCX has a lower initial minimum investment than SMDLX: RMFCX (250) vs SMDLX (1000). SMDLX annual gain was more profitable for investors over the last year : 15.14 vs. RMFCX (10.30). SMDLX return over 5 years is better than : 51.51 vs. RMFCX (36.58).
RMFCXSMDLXRMFCX / SMDLX
Total Expense Ratio0.912.1043%
Annual Report Gross Expense Ratio0.912.1043%
Fund Existence24 years26 years-
Gain YTD6.5229.00172%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets117B370M31,622%
Annual Yield % from dividends1.192.3351%
Returns for 1 year10.3015.1468%
Returns for 3 years35.1047.5074%
Returns for 5 years36.5851.5171%
Returns for 10 years96.37120.4280%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGIO35.090.93
+2.72%
Agios Pharmaceuticals
BODI8.920.16
+1.83%
The Beachbody Company Inc
BLUWU10.53N/A
N/A
Blue Water Acquisition Corp. III
MYGN4.50-0.04
-0.88%
Myriad Genetics
HII278.19-7.24
-2.54%
Huntington Ingalls Industries